Zehirlenmelerde Ekstrakorporeal Tedavi Yaklaşımları
Synopsis
Ekstrakorporeal tedaviler (EKT), konvansiyonel tıbbi tedavilere yanıt vermeyen zehirlenme vakalarında endojen veya ekzojen toksinlerin vücuttan uzaklaştırılmasıyla mortalite ve morbiditeyi önlemede kritik rol oynayan invaziv girişimlerdir. EKT’ye uygunluğu ve tedavinin etkinliğini belirleyen temel fizikokimyasal parametreler; toksinin molekül ağırlığı (MA), proteine bağlanma oranı, endojen klirensi ve dağılım hacmidir (Vd). Genel kural olarak molekül ağırlığı, proteine bağlanma oranı (%80’in altında), endojen klirensi (<4 mL/dk/kg) ve dağılım hacmi (<1-2 L/kg) düşük olan toksinlerin vücuttan elenmesinde EKT oldukça başarılıdır. Uygulanan başlıca EKT yöntemleri; aralıklı hemodiyaliz (HD), aralıklı hemofiltrasyon/hemodiafiltrasyon, sürekli renal replasman tedavisi (SRRT), hemoperfüzyon, terapötik plazma değişimi, exchange transfüzyon, albümin diyalizi, periton diyalizi ve ECMO’dur. Günümüzde gelişen diyaliz membran teknolojisi, yüksek klirens kapasitesi, yaygın erişilebilirlik ve düşük maliyet avantajları nedeniyle intoksikasyon vakalarında en sık ve ilk tercih edilen yöntem aralıklı hemodiyalizdir. Buna karşılık, hemodinamik açıdan unstabil yoğun bakım hastalarında rebound etkisini önlemek amacıyla SRRT tercih edilirken; yüksek proteine bağlanan veya yüksek molekül ağırlıklı toksinlerde hemoperfüzyon ya da plazma değişimi seçeneği değerlendirilir. En uygun EKT yönteminin seçilmesinde maruz kalınan toksinin özellikleri, hastanın tıbbi öyküsü, hemodinamik durumu ve organ fonksiyonları bütüncül olarak incelenmeli; yarar-risk dengesi titizlikle değerlendirilerek tedavi kararı vaka bazlı verilmelidir.
Extracorporeal treatments (ECTs) are invasive interventions that play a critical role in preventing mortality and morbidity by removing endogenous or exogenous toxins from the body in poisoning cases unresponsive to conventional medical therapies. The main physicochemical parameters determining suitability for ECT and treatment efficacy are the toxin's molecular weight (MW), protein binding rate, endogenous clearance, and volume of distribution (Vd). As a general rule, ECT is highly effective in removing toxins with low molecular weight, low protein binding rate (below 80%), low endogenous clearance (<4 mL/min/kg), and low volume of distribution (<1-2 L/kg). The primary ECT modalities utilized include intermittent hemodialysis (HD), intermittent hemofiltration/hemodiafiltration, continuous renal replacement therapy (CRRT), hemoperfusion, therapeutic plasma exchange, exchange transfusion, albumin dialysis, peritoneal dialysis, and ECMO. Nowadays, due to advancing dialysis membrane technology, high clearance capacity, widespread availability, and low cost advantages, intermittent hemodialysis is the most frequently preferred primary method in intoxication cases. Conversely, CRRT is preferred in hemodynamically unstable intensive care patients to prevent the rebound effect, whereas hemoperfusion or plasma exchange is evaluated for toxins with high protein binding or high molecular weight. In selecting the appropriate ECT method, the characteristics of the exposed toxin, the patient's medical history, hemodynamic status, and organ functions must be comprehensively analyzed, and treatment decisions should be made on a case-by-case basis by carefully weighing the benefit-risk ratio.
References
Ouellet, G., Bouchard, J., Ghannoum, M., & Decker, B. S. (2014, July). Available extracorporeal treatments for poisoning: overview and limitations. In Seminars in dialysis (Vol. 27, No. 4, pp. 342-349).
Ghannoum, M., Hoffman, R. S., Gosselin, S., Nolin, T. D., Lavergne, V., & Roberts, D. M. (2018). Use of extracorporeal treatments in the management of poisonings. Kidney international, 94(4), 682-688.
Ghannoum, M., Roberts, D. M., Hoffman, R. S., Ouellet, G., Roy, L., Decker, B. S., & Bouchard, J. (2014, July). A stepwise approach for the management of poisoning with extracorporeal treatments. In Seminars in Dialysis (Vol. 27, No. 4, pp. 362-370).
Martín-Reyes, G., Toledo-Rojas, R., Torres-de Rueda, Á., Sola-Moyano, E., Blanca-Martos, L., Fuentes-Sánchez, L., ... & García-González, I. (2012). Haemodialysis using high cut-off dialysers for treating acute renal failure in multiple myeloma. Nefrología (English Edition), 32(1), 35-43.
Ibrahim, R. B., Liu, C., Cronin, S. M., Murphy, B. C., Cha, R., Swerdlow, P., & Edwards, D. J. (2007). Drug removal by plasmapheresis: an evidence‐based review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 27(11), 1529-1549.
Matzke, G. R. (2002). Status of hemodialysis of drugs in 2002. Journal of Pharmacy Practice, 15(5), 405-418.
De Pont, A. C. J. (2007). Extracorporeal treatment of intoxications. Current opinion in critical care, 13(6), 668-673.
Krisper, P., & Stauber, R. E. (2007). Technology Insight: artificial extracorporeal liver support—how does Prometheus® compare with MARS®?. Nature Clinical Practice Nephrology, 3(5), 267-276.
Kawasaki, C. I., Nishi, R., Uekihara, S., Hayano, S., Kragh-Hansen, U., & Otagiri, M. (2005). How tightly can a drug be bound to a protein and still be removable by charcoal hemoperfusion in overdose cases?. Clinical Toxicology, 43(2), 95-99.
Fertel, B. S., Nelson, L. S., & Goldfarb, D. S. (2010). Extracorporeal removal techniques for the poisoned patient: a review for the intensivist. Journal of intensive care medicine, 25(3), 139-148.
Pond, S. M. (1991). Extracorporeal techniques in the treatment of poisoned patients. Medical journal of Australia, 154(9), 617-622.
Holubek, W. J., Hoffman, R. S., Goldfarb, D. S., & Nelson, L. S. (2008). Use of hemodialysis and hemoperfusion in poisoned patients. Kidney international, 74(10), 1327-1334.
Shannon, M. W. (1997). Comparative efficacy of hemodialysis and hemoperfusion in severe theophylline intoxication. Academic emergency medicine, 4(7), 674-678.
Tyagi, P. K., Winchester, J. F., & Feinfeld, D. A. (2008). Extracorporeal removal of toxins. Kidney international, 74(10), 1231-1233.
Ward, R. A., SCHMIDT, B., Hullin, J., HILLEBRAND, G. F., & Samtleben, W. (2000). A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. Journal of the American Society of Nephrology, 11(12), 2344-2350.
Yamashita, A. C. (2007). Mechanisms of solute and fluid removal in hemodiafiltration. In Hemodiafiltration (Vol. 158, pp. 50-56). Karger Publishers.
Bailey, A. R., Sathianathan, V. J., Chiew, A. L., Paterson, A. D., Chan, B. S., & Arora, S. (2011). Comparison of intermittent haemodialysis, prolonged intermittent renal replacement therapy and continuous renal replacement haemofiltration for lithium toxicity: a case report. Critical Care and Resuscitation, 13(2), 120.
Calello, D. P., Liu, K. D., Wiegand, T. J., Roberts, D. M., Lavergne, V., Gosselin, S., ... & Ghannoum, M. (2015). Extracorporeal treatment for metformin poisoning: systematic review and recommendations from the Extracorporeal Treatments in Poisoning Workgroup. Critical care medicine, 43(8), 1716-1730.
Roberts, D. M., Yates, C., Megarbane, B., Winchester, J. F., Maclaren, R., Gosselin, S., ... & Ghannoum, M. (2015). Recommendations for the role of extracorporeal treatments in the management of acute methanol poisoning: a systematic review and consensus statement. Critical care medicine, 43(2), 461-472.
Ghannoum, M., Bouchard, J., Nolin, T. D., Ouellet, G., & Roberts, D. M. (2014, July). Hemoperfusion for the treatment of poisoning: technology, determinants of poison clearance, and application in clinical practice. In Seminars in dialysis (Vol. 27, No. 4, pp. 350-361).
RAHMAN, M. H., HAQQIE, S. S., & McGOLDRICK, M. D. (2006). Acute hemolysis with acute renal failure in a patient with valproic acid poisoning treated with charcoal hemoperfusion. Hemodialysis International, 10(3), 256-259.
Szczepiorkowski, Z. M., Winters, J. L., Bandarenko, N., Kim, H. C., Linenberger, M. L., Marques, M. B., ... & Shaz, B. H. (2010). Apheresis Applications Committee of the American Society for Apheresis Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher, 25(3), 83-177.
Schutt, R. C., Ronco, C., & Rosner, M. H. (2012, March). The role of therapeutic plasma exchange in poisonings and intoxications. In Seminars in dialysis (Vol. 25, No. 2, pp. 201-206). Oxford, UK: Blackwell Publishing Ltd.
Jander, S., Bischoff, J., & Woodcock, B. G. (2000). Plasmapheresis in the treatment of Amanita phalloides poisoning: II. A review and recommendations. Therapeutic apheresis, 4(4), 308-312.
PIERGA, J. Y., BEUEZEBOC, P., Dorval, T., Palangie, T., & Pouillart, P. (1992). Favourable outcome after plasmapheresis for vincristine overdose. Lancet (British edition), 340(8812).
Schönermarck, U., & Bosch, T. (2003). Vascular access for apheresis in intensive care patients. Therapeutic Apheresis and Dialysis, 7(2), 215-220.
Manikian, A., Stone, S., Hamilton, R., Foltin, G., Howland, M. A., & Hoffman, R. S. (2002). Exchange transfusion in severe infant salicylism. Veterinary and human toxicology, 44(4), 224-227.
SANCAK, R., KÜCÜKÖDÜK, S., TASDEMIR, H. A., & BELET, N. (1999). Exchange transfusion treatment in a newborn with phenobarbital intoxication. Pediatric emergency care, 15(4), 268-270.
Wittebole, X., & Hantson, P. (2011). Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure. Clinical Toxicology, 49(9), 782-793.
Sen, S., Ratnaraj, N., Davies, N. A., Mookerjee, R. P., Cooper, C. E., Patsalos, P. N., ... & Jalan, R. (2003). Treatment of phenytoin toxicity by the molecular adsorbents recirculating system (MARS). Epilepsia, 44(2), 265-267.
Dichtwald, S., Dahan, E., Adi, N., Moses, A., & Sorkine, P. (2010). Molecular adsorbent recycling system therapy in the treatment of acute valproic acid intoxication. The Israel Medical Association journal: IMAJ, 12(5), 307-308.
Banner, W. (1996). Risks of extracorporeal membrane oxygenation: is there a role for use in the management of the acutely poisoned patient?. Journal of Toxicology: Clinical Toxicology, 34(4), 365-371.
Chyka, P. A. (1996). Benefits of extracorporeal membrane oxygenation for hydrocarbon pneumonitis. Journal of Toxicology: Clinical Toxicology, 34(4), 357-363.
De Lange, D. W., Sikma, M. A., & Meulenbelt, J. (2013). Extracorporeal membrane oxygenation in the treatment of poisoned patients. Clinical Toxicology, 51(5), 385-393.
Ghannoum, M., Bouchard, J., Nolin, T. D., Ouellet, G., & Roberts, D. M. (2014, July). Hemoperfusion for the treatment of poisoning: technology, determinants of poison clearance, and application in clinical practice. In Seminars in dialysis (Vol. 27, No. 4, pp. 350-361).